MEDICAL PROPERTIES TRUST, INC.
boothcheck covers MEDICAL PROPERTIES TRUST, INC. (MPT) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed June 27, 2026.
At $4.53 Medical Properties Trust trades around 0.6x book, a discount that says the market still doubts the post-crisis recovery. The price pays a multiple of book that no sustainable return record cleanly supports, so this is a balance-sheet and re-tenanting bet, not an earnings-multiple one. The recovery is underway. Q1 2026 returned to profit with normalized FFO of $0.14 per share, and management says re-tenanting of former Steward and Prospect hospitals is ramping rent toward full levels by
Is MPT overvalued? See what's priced in →
473 institutional managers reported holding MPT in 13F filings for the quarter ended 2026-03-31. Together they hold about 58% of the company; the top 10 hold 39%. 61 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 131.6M shares were sold short as of the 2026-06-15 count, about 22% of shares outstanding (24.2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MPT's share count grew 1.7% over the past five years. It pays a dividend, and has paid one every year in our records (16 and counting); the current rate is $0.33 a share annually. Cash returned over the past three years: $834.78M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at MPT over the trailing three years: 2024: 1 buy totaling $49k; 2025: 1 buy totaling $43k. 13 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MPT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-10 | -15.7% | -35.1% |
| 2023-11-10 | +9.7% | -19.2% |
| 2024-03-01 | +2.2% | +11.4% |
| 2024-05-30 | -1.6% | -7.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MPT's latest 8-K filings: 2026-08-10 (items 1.01, 2.03, 9.01); 2026-08-10 (items 2.02, 7.01, 9.01); 2026-06-01 (items 5.07, 9.01); 2026-04-30 (items 2.02, 9.01); 2026-02-19 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.